GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pro Medicus Ltd (FRA:PMC) » Definitions » Shares Outstanding (EOP)

Pro Medicus (FRA:PMC) Shares Outstanding (EOP) : 104.43 Mil (As of Jun. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Pro Medicus Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Pro Medicus's shares outstanding for the quarter that ended in Jun. 2024 was 104.43 Mil.

Pro Medicus's quarterly shares outstanding declined from Dec. 2023 (104.46 Mil) to Jun. 2024 (104.43 Mil). It means Pro Medicus bought back shares from Dec. 2023 to Jun. 2024 .

Pro Medicus's annual shares outstanding declined from Jun. 2023 (104.43 Mil) to Jun. 2024 (104.43 Mil). It means Pro Medicus bought back shares from Jun. 2023 to Jun. 2024 .


Pro Medicus Shares Outstanding (EOP) Historical Data

The historical data trend for Pro Medicus's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pro Medicus Shares Outstanding (EOP) Chart

Pro Medicus Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 103.95 104.21 104.28 104.43 104.43

Pro Medicus Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 104.28 104.43 104.43 104.46 104.43

Competitive Comparison of Pro Medicus's Shares Outstanding (EOP)

For the Health Information Services subindustry, Pro Medicus's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pro Medicus's Shares Outstanding (EOP) Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pro Medicus's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Pro Medicus's Shares Outstanding (EOP) falls into.



Pro Medicus Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Pro Medicus  (FRA:PMC) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Pro Medicus Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of Pro Medicus's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


Pro Medicus Business Description

Traded in Other Exchanges
Address
450 Swan Street, Richmond, VIC, AUS, 3121
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.

Pro Medicus Headlines

From GuruFocus

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 25,000 Shares

By GuruFocus Research GuruFocus Editor 11-16-2009

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 81,000 Shares

By GuruFocus Research GuruFocus Editor 08-13-2010

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 11-04-2010

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 08-05-2010

Weekly CFO Buys Highlight: PMC, ZBB

By gurujk gurujk 06-25-2012